Collectively, these findings demonstrated that overexpression of GSTM1 inhibits the activation of TGF-β-induced mouse CFs and prevents the development of fibrosis. The gene discussed is GSTM1; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.